| 000 | 01482 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513123325.0 | ||
| 264 | 0 | _c19970911 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0934-9723 | ||
| 024 | 7 |
_a10.1007/BF02471911 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReisinger, E C | |
| 245 | 0 | 0 |
_aIn vitro activity of trimethoprim against Borrelia burgdorferi. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cJun 1997 |
||
| 300 |
_a458-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 |
_aAnti-Infective Agents, Urinary _xpharmacology |
| 650 | 0 | 4 |
_aBorrelia burgdorferi Group _xdrug effects |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 |
_aCulture Media _xchemistry |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xpharmacology |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aSulfamethoxazole _xpharmacology |
| 650 | 0 | 4 |
_aTrimethoprim _xpharmacology |
| 700 | 1 | _aWendelin, I | |
| 700 | 1 | _aGasser, R | |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 16 _gno. 6 _gp. 458-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02471911 _zAvailable from publisher's website |
| 999 |
_c9228657 _d9228657 |
||